ClinicalTrials.Veeva

Menu

Endophenotype Characterization of a Family Psychiatric Disorder (EnBiGen)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

Healthy Volunteer

Treatments

Genetic: Endophenotype and sequencing

Study type

Interventional

Funder types

Other

Identifiers

NCT02843997
38RC14.321

Details and patient eligibility

About

Bipolar disorder is a chronic and frequent mood pathology, that impacts on emotional and socio-professional life of sick subjects, and also increase mortality by suicide. Suicide is considered as a bipolar disorder result.

The main goal of this study is the endophenotype characterization from a clinical and cognitive point of view, of a bipolar spectrum's disorder present in a family, and then highlight a mutation of one of the genes involved is this disorder.

Full description

Heritability of bipolar disorder is now well established, but seems to be multifactorial in most of the cases.

The use of an endophenotype characterized in a family presenting numerous bipolar sufferers enable to reflect the expression of simpler genetic variants than those involved in the disease, and might enable the identification of genes involved in the etiopathogenesis of this endophenotype.

Enrollment

29 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Members of a family adult (more than 18 years)
  • Signed informed consents
  • Registered to a French social security or possesor of the European Health Insurance Card

Exclusion criteria

Clinical part :

  • Refusal to sign the participation study consent.
  • Organic affection likely to affect cognitive abilities and brain structures or acute decompensation of a bipolar disorder.

Genetic part :

  • Refusal to sign the genetic sample consent.

Trial design

29 participants in 1 patient group

Healthy volunteers
Other group
Description:
Members of a family
Treatment:
Genetic: Endophenotype and sequencing

Trial contacts and locations

1

Loading...

Central trial contact

John Rendu, Doctor; Jérôme Holtzmann, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems